Comparative Efficacy of Anthracycline-Free and Anthracycline-Containing Neoadjuvant Chemoimmunotherapy Regimens for Triple-Negative Breast Cancer
TRANSLATIONAL ONCOLOGY(2025)
Key words
PD-1/PD-L1 Inhibitors,Anthracycline-free regimens,Triple-negative breast cancer,Neoadjuvant therapy,Real-world study
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined